Experimental Treatment for Neuroblastoma Earns Rare Pediatric Disease Designation
source: pixabay.com

Experimental Treatment for Neuroblastoma Earns Rare Pediatric Disease Designation

According to a story from BioSpace, the radiopharmaceutical company Clarity Pharmaceuticals has recently announced that the US Food and Drug Administration (FDA) has granted Rare Pediatric Disease designation to its…

Continue Reading Experimental Treatment for Neuroblastoma Earns Rare Pediatric Disease Designation
Study: Nuplazid as a Treatment for Psychosis in Parkinson’s Disease Patients
source: pixabay.com

Study: Nuplazid as a Treatment for Psychosis in Parkinson’s Disease Patients

Acadia Pharmaceuticals recently released the results of their Phase 3 trial of Nuplazid, a treatment for the psychosis that Parkinson's disease patients experience. This medication has been approved since 2016,…

Continue Reading Study: Nuplazid as a Treatment for Psychosis in Parkinson’s Disease Patients
Patients with Lesch-Nyhan Syndrome Have Biochemically Altered Skin, Urine, and Spinal Fluid
StockSnap / Pixabay

Patients with Lesch-Nyhan Syndrome Have Biochemically Altered Skin, Urine, and Spinal Fluid

According to News Medical, a recent international study designed to understand Lesch-Nyhan syndrome and its potential treatments discovered something intriguing: biochemical changes in the skin, cerebrospinal fluid, and urine. Now,…

Continue Reading Patients with Lesch-Nyhan Syndrome Have Biochemically Altered Skin, Urine, and Spinal Fluid
Filmmaker with Muscular Dystrophy Wins Award for “Muscle Warriors” Documentary
source: pixabay.com

Filmmaker with Muscular Dystrophy Wins Award for “Muscle Warriors” Documentary

  According to Disability Horizons, an extremely talented filmmaker with muscular dystrophy recently won an Award of Recognition from The Best Shorts Film Competition. Stephanie Castelete-Tyrrell's film, entitled Muscle Warriors, documents…

Continue Reading Filmmaker with Muscular Dystrophy Wins Award for “Muscle Warriors” Documentary
Consumers with Allergies, EoE Worry When FDA Relaxes Food Labeling Guidelines
https://pixabay.com/en/vegetables-carrot-food-healthy-1085063/

Consumers with Allergies, EoE Worry When FDA Relaxes Food Labeling Guidelines

  Stacey Saiontz is many things: a worker, a wife, a mother. But right now, she is concerned. As an allergy parent, or a parent whose child has severe food…

Continue Reading Consumers with Allergies, EoE Worry When FDA Relaxes Food Labeling Guidelines
NORD Announces Eleven New Grants for Rare Disease Research
source: pixabay.com

NORD Announces Eleven New Grants for Rare Disease Research

According to a story from PR Newswire, the National Organization for Rare Disorders (NORD) has recently awarded a total of eleven new grant awards that will help fund essential research…

Continue Reading NORD Announces Eleven New Grants for Rare Disease Research
Study Finds That Neuromyelitis Optica Patients Could Face Weakened Bones and Fractures
source: pixabay.com

Study Finds That Neuromyelitis Optica Patients Could Face Weakened Bones and Fractures

According to a story from Neurology Advisor, a recent study has found that patients living with neuromyelitis optica spectrum disorder (NMOSD) are at an increased risk of experiencing bone loss,…

Continue Reading Study Finds That Neuromyelitis Optica Patients Could Face Weakened Bones and Fractures
NDA to be Submitted for Potential Paroxysmal Nocturnal Hemoglobinuria Treatment
source: pixabay.com

NDA to be Submitted for Potential Paroxysmal Nocturnal Hemoglobinuria Treatment

According to a story from globenewswire.com, the biopharmaceutical company Apellis Pharmaceuticals, Inc. has announced that it is currently making plans to submit a New Drug Application (NDA) to the US…

Continue Reading NDA to be Submitted for Potential Paroxysmal Nocturnal Hemoglobinuria Treatment
Acute Myeloid Leukemia Treatment Granted the Investigational New Drug Designation
source: pixabay.com

Acute Myeloid Leukemia Treatment Granted the Investigational New Drug Designation

Immune-Onc Therapeutics recently received clearance from the FDA to begin trials of IO-202, a treatment for acute myeloid leukemia (AML). This news comes after the cancer immunotherapy company filed an…

Continue Reading Acute Myeloid Leukemia Treatment Granted the Investigational New Drug Designation